MARKET

ACRS

ACRS

Aclaris Therapeutics Inc
NASDAQ
1.240
+0.040
+3.33%
Opening 11:43 02/22 EST
OPEN
1.190
PREV CLOSE
1.200
HIGH
1.265
LOW
1.190
VOLUME
450.00K
TURNOVER
0
52 WEEK HIGH
13.20
52 WEEK LOW
0.5902
MARKET CAP
87.84M
P/E (TTM)
-0.7438
1D
5D
1M
3M
1Y
5Y
Pacira (PCRX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
NASDAQ · 2d ago
Weekly Report: what happened at ACRS last week (0212-0216)?
Weekly Report · 3d ago
Aclaris Therapeutics Inc: Statement of acquisition of beneficial ownership by individuals
Press release · 02/15 02:04
Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
NASDAQ · 02/13 14:40
Weekly Report: what happened at ACRS last week (0205-0209)?
Weekly Report · 02/12 09:12
Aclaris Therapeutics Inc: Initial statement of beneficial ownership of securities
Press release · 02/08 16:01
Aclaris Therapeutics Executive Team Undergoes Major Changes
TipRanks · 02/06 09:53
Weekly Report: what happened at ACRS last week (0129-0202)?
Weekly Report · 02/05 09:13
More
About ACRS
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a pipeline of drug candidates to address the needs of patients with immuno-inflammatory diseases. The Company has a multi-stage portfolio of drug candidates powered by a robust research and development (R&D) engine exploring protein kinase regulation. The Company operates through two segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. The contract research segment includes provision of laboratory services. The Company is also engaged in identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize its novel drug candidates.

Webull offers Aclaris Therapeutics Inc stock information, including NASDAQ: ACRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACRS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACRS stock methods without spending real money on the virtual paper trading platform.